Bucillamine had already gone through a Phase 2 with the FDA. Safety wise Bucillamine has been proven non-toxic at high dosing. Which is what they want to do in the Phase 3 for Covid-19 treatment.
In all likeliness it should be going through the fast track program.
Market Data 
Markets 
AI
